Abstract
TCF1 (transcription factor 1) encoding hepatocyte nuclear factor 1α (HNF1α) is mutated in 50% of liver cell adenomas, a benign tumor closely associated with oral contraceptive use. These genetic alterations inactivate both alleles, leading to the absence of wild-type HNF1α expression in liver cell adenomas. To search for a role of HNF1α in other hormone-related neoplasias, we screened for HNF1α mutations in a series of 36 endometrial carcinomas, 29 breast carcinomas and 20 ovarian epithelial tumors. HNF1α mutations were identified in 4/36 (11%) of endometrial tumors. No mutation was found in ovarian and breast tumors. HNF1α mutations were somatic in all cases, monoallelic in three cases and biallelic in one case. These results suggest that HNF1α may contribute to endometrial carcinogenesis through complete HNF1α inactivation like in liver cell adenoma or by haploinsufficiency like in MSI-H colorectal cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- HNF1:
-
hepatocyte nuclear factor 1α
- TCF1:
-
transcription factor 1
- MODY3:
-
maturity-onset diabetes of the young type 3
- MSI-H:
-
microsatellite instability high
- MSS:
-
microsatellite stable
- LOH:
-
loss of heterozygosity
References
Aguanno A, Afar R and Albert VR . (1996). J. Biol. Chem., 271, 4528–4538.
Akiyama TE, Ward JM and Gonzalez FJ . (2000). J. Biol. Chem., 275, 27117–27122.
Bacq Y, Jacquemin E, Balabaud C, Jeannot E, Scotto B, Branchereau S, Laurent C, Bourlier P, Pariente D, de Muret A, Fabre M, Bioulac-Sage P and Zucman-Rossi J . (2003). Gastroenterology, 125, 1470–1475.
Baumhueter S, Mendel DB, Conley PB, Kuo CJ, Turk C, Graves MK, Edwards CA, Courtois G and Crabtree GR . (1990). Genes Dev., 4, 372–379.
Bluteau O, Jeannot E, Bioulac-Sage P, Marqués JM, Blanc JF, Bui H, Beaudoin JC, Franco D, Balabaud C, Laurent-Puig P and Zucman-Rossi J . (2002). Nat. Genet., 32, 312–315.
Bluteau O, Legoix P, Bayer J, Bioulac-Sage P, Flejou JF, Capron F, Monges G, Brechot C, Thomas G, Laurent-Puig P and Zucman-Rossi J . (1999a). Gastroenterol. Clin. Biol., 23, 1225–1232.
Bluteau O, Legoix P, Laurent-Puig P and Zucman-Rossi J . (1999b). Biotechniques, 27, 1100–1102.
Cereghini S, Yaniv M and Cortese R . (1990). EMBO J., 9, 2257–2263.
Chi YI, Frantz JD, Oh BC, Hansen L, Dhe-Paganon S and Shoelson SE . (2002). Mol. Cell, 10, 1129–1137.
Chouard T, Blumenfeld M, Bach I, Vandekerckhove J, Cereghini S and Yaniv M . (1990). Nucleic Acids Res., 18, 5853–5863.
Courtois G, Morgan JG, Campbell LA, Fourel G and Crabtree GR . (1987). Science, 238, 688–692.
Ellard S . (2000). Hum. Mutat., 16, 377–385.
Frain M, Swart G, Monaci P, Nicosia A, Stampfli S, Frank R and Cortese R . (1989). Cell, 59, 145–157.
Henderson BE, Ross R and Bernstein L . (1988). Cancer Res., 48, 246–253.
Ishii Y, Hansen AJ and Mackenzie PI . (2000). Mol. Pharmacol., 57, 940–947.
Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, Monges G, Thomas G, Bioulac-Sage P and Zucman-Rossi J . (2001). Gastroenterology, 120, 1763–1773.
Laurent-Puig P, Plomteux O, Bluteau O, Zinzindohoue F, Jeannot E, Dahan K, Kartheuser A, Chapusot C, Cugnenc PH and Zucman-Rossi J . (2003). Gastroenterology, 124, 1311–1314.
Livak KJ and Schmittgen TD . (2001). Methods, 25, 402–408.
Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS and Bell GI et al (1996). Nature, 384, 455–458.
Acknowledgements
We thank Emmanuelle Jeannot (Inserm U434), Céline Boulard (I Curie), Rachida Bouarich (I Curie, UMR144 CNRS) and Evelyne Aladel (HEGP) for their help in mutation screening and excellent technical assistance. This work was supported by the association de la Recherche sur le Cancer no 3108 and the Fondation de France.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rebouissou, S., Rosty, C., Lecuru, F. et al. Mutation of TCF1 encoding hepatocyte nuclear factor 1α in gynecological cancer. Oncogene 23, 7588–7592 (2004). https://doi.org/10.1038/sj.onc.1207989
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207989
Keywords
This article is cited by
-
A Bayesian ensemble approach with a disease gene network predicts damaging effects of missense variants of human cancers
Human Genetics (2013)
-
Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines
British Journal of Cancer (2006)